| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.39 | 0.6 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |